BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23063490)

  • 1. A sensitive cell-based method to screen for selective inhibitors of SMS1 or SMS2 using HPLC and a fluorescent substrate.
    Zama K; Mitsutake S; Watanabe K; Okazaki T; Igarashi Y
    Chem Phys Lipids; 2012 Oct; 165(7):760-8. PubMed ID: 23063490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
    Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
    Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a quantitative biochemical and cellular sphingomyelin synthase assay using mass spectrometry.
    Chen Y; Yurek DA; Yu L; Wang H; Ehsani ME; Qian YW; Konrad RJ; Jiang XC; Kuo MS; Cao G; Wang J
    Anal Biochem; 2013 Jul; 438(1):61-6. PubMed ID: 23535273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis.
    Ding T; Li Z; Hailemariam T; Mukherjee S; Maxfield FR; Wu MP; Jiang XC
    J Lipid Res; 2008 Feb; 49(2):376-85. PubMed ID: 17982138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and characterization of selective human sphingomyelin synthase 2 inhibitors.
    Adachi R; Ogawa K; Matsumoto SI; Satou T; Tanaka Y; Sakamoto J; Nakahata T; Okamoto R; Kamaura M; Kawamoto T
    Eur J Med Chem; 2017 Aug; 136():283-293. PubMed ID: 28505533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A facile method for monitoring sphingomyelin synthase activity in HeLa cells using liquid chromatography/mass spectrometry.
    Sundaraswamy PM; Minami Y; Jayaprakash J; B Gowda SG; Takatsu H; Gowda D; Shin HW; Hui SP
    Analyst; 2024 Jun; 149(12):3293-3301. PubMed ID: 38713069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation.
    Matsumoto G; Hashizume C; Watanabe K; Taniguchi M; Okazaki T
    Mol Med; 2019 Dec; 25(1):56. PubMed ID: 31847800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity.
    Ding T; Kabir I; Li Y; Lou C; Yazdanyar A; Xu J; Dong J; Zhou H; Park T; Boutjdir M; Li Z; Jiang XC
    J Lipid Res; 2015 Mar; 56(3):537-545. PubMed ID: 25605874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice.
    Dong J; Liu J; Lou B; Li Z; Ye X; Wu M; Jiang XC
    J Lipid Res; 2006 Jun; 47(6):1307-14. PubMed ID: 16508036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor.
    Li Y; Huang T; Lou B; Ye D; Qi X; Li X; Hu S; Ding T; Chen Y; Cao Y; Mo M; Dong J; Wei M; Chu Y; Li H; Jiang XC; Cheng N; Zhou L
    Eur J Med Chem; 2019 Feb; 163():864-882. PubMed ID: 30580239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal permeability barrier function and sphingolipid content in the skin of sphingomyelin synthase 2 deficient mice.
    Nomoto K; Itaya Y; Watanabe K; Yamashita T; Okazaki T; Tokudome Y
    Exp Dermatol; 2018 Aug; 27(8):827-832. PubMed ID: 29345004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of fluorescent ceramide and sphingomyelin analogs: a novel approach for in vivo monitoring of sphingomyelin synthase activity.
    Huang T; Li X; Hu S; Zhao B; Chen P; Liu X; Ye D; Cheng N
    Lipids; 2014 Oct; 49(10):1071-9. PubMed ID: 25108416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of sphingomyelin synthase 1 by small interference RNA is associated with enhanced ceramide production and apoptosis after photodamage.
    Separovic D; Semaan L; Tarca AL; Awad Maitah MY; Hanada K; Bielawski J; Villani M; Luberto C
    Exp Cell Res; 2008 May; 314(8):1860-8. PubMed ID: 18374917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of liver total sphingomyelin synthase deficiency on plasma lipid metabolism.
    Li Z; Chiang YP; He M; Zhang K; Zheng J; Wu W; Cai J; Chen Y; Chen G; Chen Y; Dong J; Worgall TS; Jiang XC
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158898. PubMed ID: 33545384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of the selective sphingomyelin synthase 2 inhibitors with the novel structure of oxazolopyridine.
    Qi XY; Cao Y; Li YL; Mo MG; Zhou L; Ye DY
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3511-3515. PubMed ID: 28619536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingomyelin synthase SMS2 displays dual activity as ceramide phosphoethanolamine synthase.
    Ternes P; Brouwers JF; van den Dikkenberg J; Holthuis JC
    J Lipid Res; 2009 Nov; 50(11):2270-7. PubMed ID: 19454763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 1,8-naphthyridin-2-one derivative as a potent and selective sphingomyelin synthase 2 inhibitor.
    Yukawa T; Nakahata T; Okamoto R; Ishichi Y; Miyamoto Y; Nishimura S; Oikawa T; Kubo K; Adachi R; Satomi Y; Nakakariya M; Amano N; Kamaura M; Matsunaga N
    Bioorg Med Chem; 2020 Apr; 28(7):115376. PubMed ID: 32088125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells.
    Tafesse FG; Huitema K; Hermansson M; van der Poel S; van den Dikkenberg J; Uphoff A; Somerharju P; Holthuis JC
    J Biol Chem; 2007 Jun; 282(24):17537-47. PubMed ID: 17449912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression.
    Li Y; Dong J; Ding T; Kuo MS; Cao G; Jiang XC; Li Z
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1513-20. PubMed ID: 23640498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.
    Liu J; Zhang H; Li Z; Hailemariam TK; Chakraborty M; Jiang K; Qiu D; Bui HH; Peake DA; Kuo MS; Wadgaonkar R; Cao G; Jiang XC
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):850-6. PubMed ID: 19286635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.